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Summary Epidemiological evidence indicates that mammographic dysplasia is associated with an increased
risk of breast cancer, particularly in premenopausal women. To examine biochemical associations with
mammographic dysplasia we have compared premenopausal women with different patterns of the breast
parenchyma on mammography. One group had extensive radiological dysplasia (n=30) and the other no
dysplasia (n = 16). Both groups were recruited from mammographic units in the same way and then compared
according to epidemiological risk factors, anthropometric measures, nutrient intake and plasma levels of
oestradiol, progesterone and prolactin obtained in both follicular and luteal phases of the menstrual cycle as
well as total plasma cholesterol and lipid fractions. Women with mammographic dysplasia were found to be
leaner, more often nulliparous and to consume more alcohol than women without these radiological changes.
Mammographic dysplasia and a family history of breast cancer were found to be independently associated
with significantly higher levels of high density lipoprotein cholesterol (HDL-C) after taking into account the
possible confounding effects of percentage body fat, parity and consumption of alcohol and dietary fat.
Triglyceride levels were also independently associated with a family history of breast cancer. We conclude that
further investigation is warranted of the role of plasma lipids in relation to breast cancer risk.
Epidemiological evidence indicates that the mammographic
parenchymal pattern of the breast provides information
about risk of breast cancer (Saftlas & Szclo, 1987; Goodwin
& Boyd, 1988). Several studies of different designs have now
shown an association between the mammographic
appearance of densities, referred to as 'dysplasia', and risk of
breast cancer. The risks of breast cancer found in these
studies have generally been found to be as large as or larger
than those associated with other known risk factors for the
disease.
Studies that have examined the modifying influence on
risk of age and the extensiveness of mammographic dysplasia
have found that extensive dysplasia in younger women is
associated with a substantial increase in the risk of breast
cancer compared to women of the same age with little or no
mammographic dysplasia (Boyd et al., 1982; Brisson et al.,
1982; Wolfe et al., 1987). The existence within the
population of large differences in breast cancer risk provides
an unusual opportunity to examine factors that may be
associated with risk for the disease. Differences found
between women with mammographic appearances indicating
a high or a low risk of breast cancer may lead to the
identification of factors responsible either for the aetiology
of mammographic dysplasia or for the associated risk of
cancer.
The possibility that the mammographic appearance of
dysplasia might be associated with distinctive levels of
plasma lipids was raised by earlier work. Fasting plasma
lipids were measured as possible markers of compliance in a
randomised clinical trial of dietary fat reduction in women
with mammographic dysplasia. This study was concerned
chiefly with describing changes in lipoprotein levels in
response to changes in diet and the results of this aspect of
the study have been given elsewhere (Lee-Han et al., 1988).
However, in the 41 premenopausal women with extensive
mammographic dysplasia in whom fasting lipids were
measured we noted an unusual distribution for the reported
values obtained at baseline, before dietary intervention was
started.
The percentile distribution of values obtained for high
density lipoprotein-cholesterol. (HDL-C) and triglycerides
(TG) are shown in Figure l(a). The histograms in the figure
show values from the subjects compared to the age- and sex-
specific percentile distributions for these lipids in the
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population as described by the Lipid Research Clinic
prevalence survey (Lipid Research Clinics Program
Epidemiology Committee, 1979). Individual values were
plotted on the closest percentile that they exceeded. Values
for HDL-C fell in the upper part of the distribution for the
population and 17 of the 41 values (41%) fell above the 75th
percentile for women of the same age. Triglycerides showed
a distribution in which 53% of the values were at or below
the 25th percentile. The values for total cholesterol and low
density lipoprotein-cholesterol (LDL-C) were also
predominantly in the lower end of the population
distribution (data not shown).
Because these results suggested that the distribution of
plasma lipids was altered in patients with mammographic
dysplasia we have carried out a study to examine further this
relationship, taking into account other possible influences
such as weight, nutrition and plasma sex hormones.
Methods
Selection of subjects
Subjects were recruited from the Breast Centre at Women's
College Hospital and from the National Breast Screening
Centre at the Mount Sinai Hospital, Toronto. Women aged
30-50 years were eligible to participate if they had been
examined by mammography and were found to have either
(a) no more than 25% of the breast occupied by radiological
changes of dysplasia (referred to in the results as no
dysplasia) or (b) at least 75% of the breast occupied by
dysplasia (referred to as extensive dysplasia). Mammographic
dysplasia was defined as sheet-like areas of radiological
density that were distinguished from the linear densities that
characterise prominent ducts. Subjects were required to be
menstruating regularly with cycle length no greater than 32
days. Subjects were excluded if they had a previous history
of breast cancer, if they were following a medically
prescribed diet for any reason, or if they were taking oral
contraceptives. As is discussed further below, mammographic
dysplasia is known to be associated with leanness and
nulliparity and we did not attempt to match subjects
according to these characteristics.
Eligible subjects were contacted first by letter and
subsequently by telephone. Those who indicated willingness
to take part in the study were visited in their homes by the
study dietician and measurements made (see below).
Although a large number of subjects who were eligible on
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Figure 1 Distribution of high density lipoprotein cholesterol (HDL-C) and triglycerides in two groups of women with extensive
mammographic dysplasia compared to age and sex specific population percentiles. (a) n=41 (previous work); (b) n=30 (present
study).
radiological criteria were available from these sources, as a
result of age requirements for entry to the screening centres
many were either post-menopausal or menstruating
irregularly. Few were taking oral contraceptives. Of those
who were both eligible on radiological criteria and still
menstruating regularly approximately 50% agreed to
participate. There was no evidence of a difference in
response rate according to mammographic pattern. None of
the subjects in the present study had taken part in any of
our previous studies.
Measurements
Socio-demographic information and epidemiologic data on
risk factors for breast cancer were obtained by questionnaire.
Information on current nutrient intake was obtained with
a 7-day recall form using food models to determine portion
size. Subjects were then taught to maintain food records for
a period of 4 consecutive days including one weekend.
Subjects were given digital scales and measuring cups and
spoons to weigh and measure all food and beverages
consumed during the time that food records were kept. At
the end of the 4-day period the dietician reviewed all records
for completeness.
Venous blood was taken in both follicular and luteal
phases of the menstrual cycle for measurement of oestradiol,
progesterone and. prolactin. Blood obtained in the luteal
phase of the cycle was obtained after a 12h fast and plasma
lipids measured by the Lipid Research Clinic Core
Laboratory using standard Lipid Research Clinic methods
(Manual of Laboratory Operations, Lipid Research Clinics
Program 1, 1982). Hormone assays were performed by the
Toronto Hospitals In Common laboratory. This is a non-
profit commercial laboratory with a quality control
programme run by the Canadian Society of Clinical
Chemists. Concentrations of oestradiol, progesterone and
prolactin were measured with standard radioimmunoassays.
Each subject was weighed using a portable scale and
skinfolds thickness (triceps, subscapular and iliac) was
measured using Lange calipers. Percentage body fat was
calculated from standard tables (Hendricks et al., 1983).
Data display and statistical methods
'Box-plots' were used to display the distribution of scores.
They are used commonly in exploratory data analysis to
show as fully as possible the distribution of scores and show
the distribution of the central 50% of the data values as a
box with the median value shown as a cross. The range of
the remaining data points is estimated by bars which extend
from the box for a maximum distance 1.5 times the length of
the box. Observations lying outside this estimate of the range
are shown as individual points (Velleman & Hoaglin, 1981).
Proportions were compared with the x2 statistic or
Fisher's exact test when less than five were in a cell, and
means with Student's t test (Snedecor & Cochran, 1967). Thc
relationship between mammographic pattern and plasma
lipids was examined with simple regression, analysis of
variance and analysis of covariance using the general linear
model procedure. Analysis of covariance gives the same
results as multiple regression. In addition, the data matrix of
the final model was examined for collinearity by calculating
eigenvalues using the REG procedure (SAS Users Guide:
Statistics, Version 5 Edition, 1985). All analyses were
performed with and without logarithmic transformation of
the data. The conclusions were unchanged by logarithmic
transformation and the results shown were obtained without
transformation.
Results
Characteristics of subjects
The two groups of women studied comprised 30 WOi1Cfl with
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Table I Characteristics of subjects
Dysplasia
Variable Present Absent P value
Number 30 16
Mean age (years) 38.8+5.4 40.7+5.6 0.2
Age at menarche (years) 12.33+2.4 12.19+0.8 0.77
Marital status (%)
Married 73 75
Never married 23 6 0.05
Divorced, widowed, separated 3 19
Parity (%)
0 47 19
1-2 43 50 0.08
>3 10 31
Familial breast cancer (%)
1st degree relatives 30 0
Other relatives 13 19 0.05
No relatives 57 81
Weight (kg) 57.9+6.9 76.0+18.1 0.001
Height (cm) 163.4+4.7 164.0+7.0 0.7
Quetelet index 21.7+0.0002 28.2+0.0006 0.001
Skin fold thickness
Triceps 19.5+5.5 26.7+5.0)
Subscapular 11.4+3.2 21.9+5.3 <0.0001
Illial 10.2+5.0 23.0+5.4
Values shown for continuous variables are means+standard deviations.
Table II Mean daily nutrient intake as assessed by food records
Dysplasia
Nutrient
Total Energy
Total fat
Saturated fat
Polyunsaturated fat
P/S ratio
Protein
Carbohydrate
Cholesterol
Alcohol
Present Absent P value
(g)
(%)
(g)
(%)
(g)
(%)
(g)
(%)
(g)
(%)
(mg)
(g)
1,926+562
80+28
37+6.1
32+13.5
15 +3.7
13 +6.1
6+2.2
0.52+0.29
75+20
16+2.7
203 +65
43 +6.8
400+180
18+24
1,918+478
84+85
39+4.3
32+9.2
15 +2.3
14+4.9
7+ 1.8
0.47 +0.15
70+20
15 +3.2
217+67
45 + 5.1
372+ 145
5+10
0.96
0.5
Values are mean daily intake+standard deviation.
extensive mammographic dysplasia and 16 women with
dysplasia occupying less than 25% of the breast. Table I
shows the demographic, reproductive and anthropometric
characteristics of these subjects. Compared to women with
little or no dysplasia, women with extensive dysplasia were
less likely to be married, more likely to be nulliparous and
more likely to have first degree relatives with breast cancer.
Women with dysplasia also weighed less, and as indicated by
the Quetelet index and measurements of skinfolds thickness,
had less body fat. The associations seen here between
mammographic dysplasia and leanness, nulliparity and a
family history of breast cancer have been previously
observed by others (Gravelle et al., 1982; de Waard et al.,
1984; Wolfe et al., 1980).
Women with and without extensive mammographic
dysplasia did not differ significantly in the proportion of
former or current smokers or in the average number of
hours per week spent in physical exercise (data not shown).
Nutrient intake
Table III Plasma hormones and
Dysplasia
Variable
Hormones
Follicular phase
Oestradiol (pmol I1)
Progesterone (nmolI1-
Prolactin (mgI')
Luteal phase
Oestradiol (pmolI1)
Progesterone (nmol I')
Prolactin (mgI1)
Lipids (mmol-1)
Cholesterol
HDL-C
LDL-C
VLDL-C
Triglyceride
Present
465.0+296.1
2.0+0
17.3 + 11.28
475.7+245.2
39.1 +24.8
19.8+ 15.6
4.71 +0.57
1.76+0.36
2.70+0.49
0.25 +0.12
0.94+0.41
369
2
21
436
25
Table II shows the nutrient intake of these subjects, as
assessed by the nutrient analysis of 4-day food records. The
lipids values shown are daily averages calculated for each nutrient
over the 4-day period for which records were kept. Women
with and without extensive mammographic dysplasia did not
Absent P value differ significantly in their consumption of total calories,
total fat, type of fat, protein, carbohydrate or dietary
cholesterol. Women with extensive dysplasia reported greater
1.7 +303.5 0.1 alcohol consumption, with an average daily intake of 18 g
.0+0 1.0 (approximately the equivalent of two wine glasses) compared
.1+10.3 0.06 to an average intake of 5 g per day in women without
dysplasia. Women with and without dysplasia were similar
i.9 +253.4 0.55 with respect to the intake of vitamins, including vitamin C
;.7+18.4 0.08 (data not shown).
21.2 +10.3
4.90+0.56
1.25 +0.28
3.34+0.59
0.32 +0.14
1.38 +0.5
0.20
0.27
0.0001
0.0014
0.1104
0.0068
Plasma hormones and lipids
Table III shows the results of the hormone assays from
blood taken in both follicular and luteal phases of the
menstrual cycle, and the measurement of plasma lipids
determined in fasting blood samples taken in the luteal phase
of the cycle. Compared to women without extensive
dysplasia, women with extensive mammographic dysplasia
had slightly higher levels of oestradiol in both phases of the
cycle, and slightly higher levels of progesterone in the luteal
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phase. Differences in values for follicular phase plasma
oestradiol and luteal phase plasma progesterone were closc
to, but did not achieve, conventional levels of statistical
significance.
Total plasma cholesterol values were not significantly
different between the groups, but there were substantial
differences in levels of HDL-C, LDL-C and triglycerides.
Compared to women without extensive dysplasia those with
dysplasia had higher levels of HDL-C and lower levels of
LDL-C and TG.
The plasma lipid values obtained from this group of
women with extensive mammographic dysplasia were
compared with the expected distribution in the population
with results that are shown in Figure l(b). Seventeen of the
30 (57%) subjects had values for HDL-C that fell above the
75th percentile for women of the same age and 11 (37%)
had values of HDL-C at or above the 90th percentile.
Eighteen of the 30 subjects (59%) had values for TG that
were at or below the 25th percentile. The distribution of
total cholesterol and LDL-C were again predominantly in
the lower part of the population distribution (data not
shown).
The further analyses shown in the following sections were
carried out to determine if the differences in plasma lipids
Ibound between women with and without mammographic
dysplasia could be explained by any of the other differences
found between these groups.
Associations between plasma lipids and other variables:
univariate analysis
Table IV shows the univariate associations between HDL-C,
LDL-C and triglycerides (TG) and other variables. The
variables shown were selected either because they differed
between the groups of women compared or because of a
previously described association with plasma lipids. In the
univariate analysis, mammographic dysplasia was
significantly associated with HDL-C, LDL-C and TG levels.
Weight, the Quetelet index and percentage body fat were
also all significantly associated with HDL-C, LDL-C and
TG. A family history of breast cancer in first degree relatives
was significantly associated with both HDL-C and TG.
Alcohol intake was positively associated with HDL-C level
but the association was not significant in this group of
subjects. Neither parity nor total dietary fat intake was
significantly associated in univariate analysis with any of
these plasma lipids. Dietary saturated fat was significantly
associated with triglyceride level, but not with HDL-C.
Additional analyses failed to show any significant
Table IV Plasma lipids and other variables: univariate associations
HDL-C LDL-C Triglycerides
F value P F value P F value P
Mammographic pattern 23.45 0.0001 14.51 0.0004 10.14 0.0003
Body fat % 12.72 0.001 4.81 0.0001 23.71 0.0001
Weight (kg) 12.25 0.0011 0.91 0.344 17.47 0.0001
Quetelet index 10.3 0.0025 2.1 0.154 12.27 0.0011
Family history of breast cancer 8.48 0.0009 2.05 0.14 5.18 0.01
Parity 1.23 0.30 1.90 0.16 0.54 0.59
Total fat (% calories) 0.13 0.724 0.38 0.542 2.81 0.101
Saturated fat (% calories) 0.25 0.62 0.02 0.89 5.10 0.03
Alcohol 2.44 0.13 3.09 0.09 0.73 0.39
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Figure 2 Plasma levels of high density lipoprotein cholesterol (HDL-C) and triglycerides
mammographic dysplasia and a family history of breast cancer. (Data are shown as 'box-plots';
symbols.)
accordinig to the presence of
see Methods for explanation of
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associations between plasma lipid levels and smoking,
exercise or the dietary intake of carbohydrates (data not
shown).
The separate influences of mammographic dysplasia and a
family history of breast cancer on levels of HDL-C and TG
are illustrated in Figure 2. Plasma levels of HDL-C were
highest in subjects with both mammographic dysplasia and a
family history of breast cancer, lowest in those with neither
of these risk factors and intermediate in women with
mammographic dysplasia but no family history of breast
cancer. TG levels were also influenced by both of these
variables but in the opposite direction.
Associations between plasma lipids and other variables:
multiple regression analysis
Many of the variables shown by univariate analysis to be
associated with the plasma lipids are related to each other,
particularly the classification of mammographic appearance
and weight and percentage body fat. To assess the
independent effects of these variables, we next carried out an
analysis of covariance.
Several models were examined. We included in these
models all of the variables shown in the single variable
analysis to be significantly associated with any lipoprotein
fraction, as well as any variables known as the result of
other work to be associated with HDL-C, LDL-C or TG
levels. The results of the final model are shown in Table V.
In this model percentage body fat is included because it was
more strongly associated with lipoprotein levels than any of
the indices of body size, and saturated fat was included
because it was significantly associated with levels of
lipoprotein, while total fat and other nutrients were not. A
family history of breast cancer was retained because it was
independently associated with lipid levels. Parity and alcohol
intake were not independently associated with lipid levels but
did differ significantly between women with and without
mammographic dysplasia and were included to demonstrate
their lack of influence on the association of mammographic
pattern with lipid levels.
In the final model shown in Table V, mammographic
dysplasia and a family history of breast cancer both showed
an independent and significant positive association with
HDL-C level. TG level was negatively associated with a
family history of breast cancer but not, after adjustment for
other variables, with mammographic pattern. In addition,
alcohol consumption was independently and positively
associated with TG level. Neither mammographic pattern
nor family history of breast cancer retained an independent
association with the level of LDL-C after adjustment for the
other variables shown. However, examination of the data
matrix for collinearity suggested that the lack of association
of LDL-C and TG with mammographic dysplasia could be
due to the strong association between mammographic
pattern and percentage body fat.
In the model shown, approximately 60% of the variance
in HDL-C and TG was explained by the model.
Mammographic pattern and a family history of breast cancer
alone explained 90% of the explained variance in HDL-C
level.
Discussion
These results indicate that plasma levels of HDL-C are
related to mammographic dysplasia and that levels of both
HDL-C and TG are related to a familial history of breast
cancer. The results also show evidence of an association
between mammographic dysplasia and percentage body fat
and alcohol intake. Mammographic dysplasia has previously
been described as having an inverse association with weight
(Gravelle et al., 1985; Brisson et al., 1984) and premeno-
pausal risk of disease has also been associated with leanness
(Willet et al., 1985). This is in contrast to risk of post-
menopausal breast cancer, where obesity appears to increase
risk (see Rose (1986) for a recent review).
Although both body weight and alcohol intake are known
to influence HDL-C levels, these associations did not explain
the relationships observed here between HDL-C and
mammographic dysplasia. Percentage body fat and mammo-
graphic dysplasia are, however, too closely related in these
data to determine whether TG levels were independently
associated with mammographic dysplasia.
Higher than average age- and sex-specific values of HDL-
C have now been observed in two distinct groups of subjects
with mammographic dysplasia and thus seem unlikely to be
due to chance. The observation that both HDL-C and TG
levels were related to a family history of breast cancer is
based on a very small number of subjects and should
therefore be regarded as preliminary. However, in the
present data two risk factors for breast cancer, mammo-
graphic dysplasia and a family history of breast cancer,
explained a substantial proportion of the variance in
HDL-C.
Both the nature and the mechanism of the plasma lipid
findings seen in association with mammographic dysplasia
are presently unknown. The differences seen between women
with and without extensive mammographic dysplasia both in
plasma levels or HDL-C and TG and in body fat stores
suggests that differences in fat metabolism exist between
women with and without these radiological changes.
Furthermore, differences in the quantity of fat in the breast
may explain differences in the radiographic density of the
breast on mammography.
The possibility cannot be excluded that the observed
association of plasma lipids with mammographic dysplasia is
due to hormonal influences, although previous workers and
the present study have failed to find any association between
levels of endogenous sex hormones and mammographic
features of breast tissue (Meyer et al., 1986). In the present
study concentrations of plasma sex hormones were, with the
exception of luteal phase prolactin, similar in women with
and without mammographic dysplasia, but the number of
subjects is too small to exclude possible differences of
biological significance. Furthermore, in view of the reported
association between body fat stores and menstruation
(Frisch, 1985), the selection of women with regular
menstrual cycles of defined length for this study may have
contributed to our failure to find differences in hormone
levels.
Plasma lipids have not been studied extensively in patients
with breast cancer and the studies that have been reported
Table V Plasma lipids and other variables: analysis of covariance
HDL-C LDL-C Triglycerides
F value P F value P F value P
Mammographic pattern 10.3 0.003 0.01 0.94 0.77 0.39
Body fat % 0.68 0.41 4.80 0.04 5.83 0.007
Family history of breast cancer 6.83 0.003 0.07 0.93 6.44 0.004
Parity 1.11 0.34 0.32 0.73 0.85 0.44
Saturated fat (% calories) 1.19 0.28 0.67 0.42 8.41 0.007
Alcohol 0.05 0.82 1.84 0.18 2.24 0.15
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are inconsistent in their results. Rossner and Wallgren (1984)
studied 23 post-menopausal women after surgical removal of
apparently localised breast cancer, and found that plasma
HDL-C was significantly higher in cancer patients compared
to 35 healthy controls. Miller and Erf (1956) studied eight
women after apparently curative surgical resection of breast
cancer and found significantly higher levels of HDL-C than
in blood donors free of breast cancer. The same authors
found significantly lower levels of HDL-C in women with
metastatic breast compared to controls. Feldman and Carter
(1971) studied post-menopausal women with metastatic
breast cancer and found significantly lower HDL-C levels in
cancer patients. Barclay et al. (1970, 1975) also reported a
reduction in HDL-C in women from whom blood was
obtained in the presence of either an unresected breast
tumour or of metastatic disease. Bani et al. (1986) studied
pre- and post-menopausal women before resection of breast
tumours and found a significantly lower level of HDL-C in
women with breast cancer than in controls.
In all of these reports the size of groups studied has been
small, and potential confounding variables such as age,
weight, menopausal status and alcohol intake have not been
taken into account. None the less, the reported studies all
suggest that breast cancer is associated with an abnormality
of HDL-C levels. The very limited evidence available on
patients with and without resected breast cancer suggests
that plasma levels of HDL-C may be influenced by the
presence of tumour.
Furthermore, plasma levels of HDL-C are influenced by
other factors known or suspected to affect breast cancer risk,
including female sex hormones (Srinivasan et al., 1985; Wahl
et al., 1983), parity (van Stiphout et al., 1987), dietary fat
(Jones et al., 1987; Goodwin & Boyd, 1987) and alcohol
(Graham, 1987; Williams et al., 1985).
Interest in the relationship of HDL-C to disease has to
date been focused primarily on its protective role in
coronary heart disease (Miller & Miller, 1975), a disease
from which women have some protection that appears to be
related at least in part to their higher levels of HDL-C. The
results shown here raise the possibility that HDL-C may be
related to breast cancer risk, a disorder to which women in
the Western world are especially susceptible, and suggest
that further investigation is warranted of the role of plasma
lipids in relation to this disease.
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